Third molar removal surgeries included: comparison of the use of high and low level lasers

INTERVENTION: E02.594 There will be 84 patients, who will be allocated to one of the 06 subgroups, with 14 in each subgroup. Patients will be divided into 3 groups (A, B and C) according to the strategy to control inflammatory aspects. Each group will be divided into two subgroups according to the type of instrument used to perform the mucosal incision. Thus, a total of six subgroups will compose the research. In the first group (A), there will be 28 patients who will not receive any preemptive medication. In the second group (B), there will be another 28 patients who will receive preemptive medication. 8 milligrams (mg) of dexamethasone and 100 mg of nimesulide will be administered, one hour before the surgical procedure, used only at that time. This medication will be provided by the researcher. In the third group (C), there will be another 28 patients who will be treated with Low Intensity Laser Therapy (LBI) also before the surgical procedure. The application will be carried out in four intraoral points (inside the mouth), two on each side of the incision, with a distance of 1cm between the points, with a dose of 1J per application point, with an application time of 10s per application point. , using a wavelength of 660nm ± 10nm with a power of 100mW ± 20%. On the face, three points will be irradiated (applied). Two points on the skin covering the lower portion of the masseter muscle, the first being at the mandibular angle, the second on the anterior edge of the mandible. The third point will be on the skin of the region on the anterior border of the origin of the masseter muscle. The applied dose will be 4J at each point, for 40s each application, using a wavelength of 808nm ± 10nm with a power of 100mW ± 20%. In subgroups A1, B1 and C1, there will be patients in which the mucosal inci VS2.002.001 CONDITION: Anomalies of tooth position K00‐K93 PRIMARY OUTCOME: To evaluate mean differences in clinical parameters related to inflammatory events (pain). SECONDARY OUTCOME: To evaluate mean differences in clinical parameters related to inflammatory events (edema and trismus). INCLUSION CRITERIA: Healthy volunteers; Both genres; non smokers; age between 18 and 30 years; In need of removal of the four semi‐inclusion or inclusion (not erupted in the mouth) in any inclination ratio with the distal face of the second molar, with the proximity of the branch of the jaw and in any depth.